Intranasal COVID-19 Vaccine Study
Intranasal COVID-19 Vaccine Studies in Columbus
Aventiv Research is currently participating in an investigational Phase 1 intranasal COVID-19 vaccine study at our Columbus, Ohio location. As the fight against the pandemic continues, innovative therapies to treat and/or modify the natural course of COVID-19, emerging variants, while providing easy access for the global population are urgently needed.
IGM’s Intranasal COVID-19 Vaccine Study
The primary objective of this clinical trial is to investigate the safety and tolerability of an investigational intranasal COVID-19 vaccine for five days in healthy adults.
We are specifically looking for healthy adult volunteers who:
- are 18 through 50 years of age
- have never had COVID-19 and have never received a COVID-19 vaccine or COVID-19 treatment therapy
This study requires multiple overnight stays at our 99 N. Brice Road location.
As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.
Ready to Volunteer?
Volunteer today to see if you qualify for our Phase 1, intranasal COVID-19 vaccine clinical research study. Qualified volunteers may be compensated for time and travel.